Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Later line chemotherapy causes severe side effects, impacting quality of life, but patients continue treatment to extend life and stay connected with loved ones.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Baricitinib may not always prevent relapse in alopecia areata.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Tofacitinib effectively treats Alopecia Areata.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Baricitinib is effective and safe for treating severe alopecia areata.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Tofacitinib may effectively treat folliculitis decalvans.